Physician profile
Trevor Cable
NPI 1376146241
$1,831.74
in general payments reported to CMS, 2019-2025
21 companies · $766 in 2025
The $766 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.96 · 2022: $514 · 2023: $188 · 2024: $335 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $270.09 | 2022-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $268.45 | 2024-2025 | Tremfya, Stelara |
| Sumitomo Pharma America, INC. | $264.83 | 2023-2025 | Gemtesa |
| Olympus America INC. | $183.79 | 2022-2024 | Itind System |
| Ardelyx, INC. | $148.13 | 2022-2025 | Ibsrela |
| Ipsen Biopharmaceuticals, INC | $90.61 | 2025 | Iqirvo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.33 | 2021-2023 | Trulance |
| Boston Scientific Corporation | $83.73 | 2022 | |
| Abbvie INC. | $71.54 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $67.91 | 2022-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $67.12 | 2022-2023 | Dificid |
| Nestle Healthcare Nutrition INC. | $39.05 | 2022-2023 | |
| Aimmune Therapeutics, INC. | $30.02 | 2024 | |
| Genzyme Corporation | $29.74 | 2022 | |
| Blue Earth Diagnostics | $26.25 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celltrion USA INC. | $22.72 | 2025 | Vegzelma |
| Daiichi Sankyo INC. | $17.96 | 2022 | |
| Sandoz INC. | $16.75 | 2024 | Hyrimoz |
| Blueprint Medicines Corporation | $16.18 | 2024 | Ayvakit |
| Pfizer INC. | $16.06 | 2021 | |
| Medtronic, INC. | $15.48 | 2025 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Cable listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.